Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of ixabepilone in treating patients who have
progressive or metastatic urinary tract cancer. Drugs used in chemotherapy use different ways
to stop tumor cells from dividing so they stop growing or die